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https://doi.org/10.1016/j.stemcr.2021.07.022SUMMARYRegeneration of skeletal muscle requires resident stem cells called satellite cells. Here, we report that the chromatin remodeler CHD4, a
member of the nucleosome remodeling and deacetylase (NuRD) repressive complex, is essential for the expansion and regenerative func-
tions of satellite cells. We show that conditional deletion of the Chd4 gene in satellite cells results in failure to regenerate muscle after
injury. This defect is principally associated with increased stem cell plasticity and lineage infidelity during the expansion of satellite cells,
caused by de-repression of non-muscle-cell lineage genes in the absence ofChd4. Thus, CHD4 ensures that a transcriptional program that
safeguards satellite cell identity duringmuscle regeneration ismaintained. Given the therapeutic potential ofmuscle stem cells in diverse
neuromuscular pathologies, CHD4 constitutes an attractive target for satellite cell-based therapies.INTRODUCTION
Adult skeletal muscles regenerate through a population of
muscle-resident Pax7-expressing stem cells (satellite cells
[SCs]) that are quiescent in resting conditions. Upon injury,
SCs exit quiescence and proliferate, and their progeny
either differentiate to form new muscle fibers or self-renew
to replenish the quiescent stem cell pool (Yin et al., 2013).
SC fate is controlled by an interplay of instructive and
responsive cues, which are epigenetically regulated at a
cell-autonomous level (Ermolaeva et al., 2018; Faralli
et al., 2016; Juan et al., 2011; Robinson and Dilworth,
2018; Schworer et al., 2016; Zhang et al., 2015).
The chromatin-remodeling complex NuRD (nucleosome
remodeling and deacetylase) is an epigenetic regulator
implicated in various cellular processes, such as cell-cycle
progression, DNA damage response, maintenance of
genome integrity, lineage commitment of different cell
types (including stem cells), and proliferation of cancer cells
(Gomez-del Arco et al., 2016; Kashiwagi et al., 2007; Lai and
Wade, 2011; O’Shaughnessy andHendrich, 2013; Ostapcuk
et al., 2018; Williams et al., 2004; Xu et al., 2020; Zhang et
al., 1998; Zhao et al., 2017). Different NuRD complexes
with a diverse assembly of protein components yield
distinct outcomes, including transcriptional activation orStem C
This is an open access article under the Crepression of target genes. These components include the
chromodomain-helicase-DNA-binding proteins 3 and 4
(CHD3, CHD4), which both possess helicase/ATPase activ-
ity, the class I histone deacetylases 1 and 2 (HDAC1 and
HDAC2), the metastasis-associated proteins Mta1/2/3, and
the methyl-CpG-binding domain family members MBD2
or MBD3. These core factors can assemble into mutually
exclusive CHD4/NuRD-like complexes (Le Guezennec
et al., 2006). We previously demonstrated that Chd4 main-
tains tissue homeostasis and identity of mature cardiac
and skeletal muscle (Gomez-del Arco et al., 2016) and plays
a decisive role in the de-repression of RIPK3, a key effector of
necroptosis (Sreenivasan et al., 2020).
Here, we show that CHD4 is not only an essential compo-
nent of the muscle regenerative program that sustains effi-
cient expansion of adult muscle stem cells but it is also
required to maintain their transcriptional identity.RESULTS
CHD4 expression in SCs is required for muscle
regeneration
We first assessed Chd4 expression in quiescent SCs
(QSCs) isolated from resting muscle of wild-type (WT)ell Reports j Vol. 16 j 1–10 j September 14, 2021 j ª 2021 The Authors. 1
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cence-activated cell sorting (FACS) protocol and cultured
in growth medium for 48/72 h, or differentiation
medium for 24/48/72 h. Chd4 mRNA expression was up-
regulated in proliferating SCs, decreasing during early
differentiation stages (Figure 1A). Consistently, in SCs
isolated from regenerating muscle 72 h after injury, the
peak of the proliferative response, Chd4 expression was
strongly induced (Figure 1B) at both transcript and pro-
tein levels (Figure 1C).
To assess the specific contribution of Chd4 to SC
functions, we generated mice with conditional deletion
of Chd4 in SCs (Chd4DPax7ER mice) by intercrossing
Chd4fl/fl and Pax7CRE-ER mice (Nishijo et al., 2009; Wil-
liams et al., 2004). Loss of Chd4 after tamoxifen (TMX)
administration was verified by RT-PCR (Figure S1A). In
the absence of injury, muscles of Chd4DPax7ER and
Chd4f/fl (control) mice showed no significant differences
in muscle morphology (Figure S1B), and the number of
Pax7+ cells was similar, with a tendency to decrease by
90 days after TMX administration (Figure S1C). At
7 days after injury, muscle regeneration in Chd4DPax7ER
mice was severely impaired, as indexed by the reduced
size of myofibers positive for embryonic myosin
heavy chain (eMHC), a marker of newly formed myofib-
ers (Figure 1D). The muscles of Chd4DPax7ER mice
continued to show smaller eMHC+ and centrally nucle-
ated fibers (indicative of regeneration) than control
mice at 14 or 21 days after injury (Figures S1D and
S1E). This persistent regenerative defect in Chd4DPax7ER
mice was exacerbated after two rounds of muscle injury
(Figure S1F).Figure 1. Chd4 is required for the proliferative expansion of SCs
(A) Chd4 mRNA relative expression in QSCs, and in SCs under prolifera
medium [DM]) conditions at the indicated time points in culture from
QSCs set to 1 (from left to right, n = 13, 9, 6, 7, 9, or 7 mice, respec
(B) Representative pictures and quantification of Chd4 in SCs (Pax7+) f
with CTX (n = 33 or 60 cells, respectively, from four mice). The sum o
5 mm.
(C) Chd4 mRNA expression in freshly isolated SCs from non-injured mu
to housekeeping gene Rpl7, with the QSCs set to 1 (n = 12 or 9 mice,
(D) Representative pictures of sections of regenerating muscles from
stained with hematoxylin and eosin and antibodies against eMHC. Sca
sectional area (mm2) of regenerating fibers from TMX-treated Chd4fl/f
(E) Average time until first division during live time-lapse microsco
Chd4DPax7ER mice (138 or 58 individual cells from three different mic
(F) Percentage of BrdU+ SCs cultured in GM for either 72 or 120 h (l
throughout 4 days after isolation and culture in GM (middle), and the
from TMX-treated Chd4fl/f and Chd4DPax7ER mice (n = 4 independent e
(G) Relative number of total and proliferating SCs after FACS purificatio
(n = 4 mice/group).
(H) Representative pictures and quantification of proliferating (P
n = 5 mice/group) in muscles of TMX-treated Chd4fl/f or Chd4DPax7ER mCHD4 is essential for efficient SC proliferation during
muscle regeneration
We next determined myogenic functions of SCs upon
quiescence exit. Compared with Chd4fl/fl, Chd4DPax7ER SCs
exhibit proliferation arrest as revealed by live time-lapse
microscopy (Figure 1E), 5-bromo-20-deoxyuridine (BrdU)
incorporation in growth-promoting conditions (Figure 1F),
and clonogenic assays (Figure 1F). Importantly, acute Chd4
deletion ex vivo by adenovirus-CRE (Ad-CRE, compared
with Ad-GFP) in SCs isolated from Chd4fl/fl mice (Fig-
ure S1G) induced a proliferation arrest, thereby excluding
potential indirect effects of long-term TMX-mediated
Chd4 deletion (Figure S1G).
Consistently, compared with Chd4fl/fl, the total number
and fraction of proliferating (PAX7+/EdU+ or PAX7+/
KI67+) SCs from regenerating muscles in vivo were dramat-
ically lower in Chd4DPax7ER mice (Figures 1G and 1H), coin-
cidingwith an increased number of differentiating (Myoge-
nin, Myog+) SCs (Figure 1H), and a reduced proportion of
self-renewed SCs (Figure S1H). Consistently, impairment
of self-renewal and regeneration in Chd4DPax7ER mice was
exacerbated upon repetitive injuries (Figure S1F). Further-
more, regenerating myofibers in Chd4DPax7ER mice con-
tained significantly fewer myonuclei (Figure S1I), a feature
also observed in in vitro-formed myotubes (Figure S1J).
To obtain amolecular understanding of howChd4 affects
SC proliferation, we performed whole-transcriptome ana-
lyses of Chd4fl/fl SCs cultured in growth medium for 72 h
with acute Ad-CRE-mediated deletion of Chd4, resulting
in the upregulation of 1,975 genes, and the downregula-
tion of 1,843 genes (adjusted p < 0.01), compared with
Ad-GFP transduced controls (Figure 2A). The upregulatedduring muscle regeneration
tive (in growth medium [GM]) or differentiation (in differentiation
WT mice. Data were normalized to housekeeping gene Rpl7 with the
tively).
rom non-injured muscles fromWTmice, or at 72 h after muscle injury
f the Chd4 fluorescence intensity per cell is represented. Scale bar,
scles and at 72 h after muscle injury with CTX. Data were normalized
respectively).
TMX-treated Chd4fl/f and Chd4DPax7ER mice at day 7 after injury,
le bar, 10 mm (top), 5 mm (bottom). Frequency distribution of cross-
and Chd4DPax7ER mice (n = 4 and 5 mice, respectively) (bottom).
py, and percentage of dividing SCs from TMX-treated Chd4fl/f and
e, respectively).
eft), the number of SC colonies with more than five cells counted
number of SCs per well after seeding 50 cells/well at time 0 (right),
xperiments).
n from TMX-treated Chd4fl/f or Chd4DPax7ERmice at 3 days after injury
ax7+/Ki67+; n = 4 mice/group) or differentiating cells (Myog;
ice at 7 days after injury. Scale bar, 50 mm.
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gesting a rapid compensatory attempt to uphold the
availability of an alternative NuRD complex. Upregulated
gene clusters were involved in cell differentiation toward
myogenesis but also other cell lineages, and downregulated
gene clusters were involved in cell-cycle and DNA meta-
bolism processes (Figure 2B). Within the upregulated
genes, we found increased Myog expression, a member of
the myogenic regulatory factor (MRF) family required for
muscle-cell differentiation (Figures 2A and S2A), and of
Cdkn1c (p57) (Figures 2A and S2B), which has been linked
to cell-cycle arrest and is required for the initiation of mus-
cle differentiation (Mademtzoglou et al., 2018; Zhang et al.,
1999). In agreement, we confirmed an upregulation of p57
and Myog in SCs isolated from regenerating muscles of
Chd4DPax7ER mice after injury (Figures S2A and S2B).
We next investigated Chd4 regulation of p57 due to its
important role in regulating growth arrest of adult SCs.
CHD4 chromatin immunoprecipitation (ChIP) followed
by PCR revealed a direct association to the p57 gene regula-
tory regions in proliferating SCs (Figure S2C). In agreement
with this, lentivirus-mediated knockdown of p57 increased
SCproliferation (Figure S2D). To determine the influence of
the upregulated p57 expression in SCs of Chd4DPax7ER mice
in vivo, we used a p57 conditional-mutant allele (Mademt-
zoglou et al., 2017) to generate Chd4DPax7ER;p57DPax7ER
double-mutant mice. Genetic inactivation of p57 in
Chd4-deficient SCs failed to restore SC proliferation or
normal muscle regeneration (Figure S2E), and also did
not affect the dysregulation of genes from other lineages
in vivo (Figure S2F), showing that CHD4 controls SC func-
tion through the concurrent regulation of several target
genes with distinct biological functions.
CHD4 maintains the transcriptional identity of SCs
during muscle regeneration
To gain a deeper mechanistic understanding of the action
of CHD4 in SCs in vivo, we performed RNA sequencing
(RNA-seq) and transposase-accessible chromatin high-
throughput sequencing (ATAC-seq) on SCs isolated fromFigure 2. Chd4 controls the expression of cell-cycle regulators an
(A) Volcano plot (log10(p) versus log2(fold change)) showing RNA
(control) (n = 4 independent experiments).
(B) GO analysis of the Biological Process database and Hallmark data
(C) Volcano plot showing RNA-seq results from FACS-purified SCs at 3
mice (n = 4 mice/group).
(D) TSEA analyses comparing gene expression of Chd4 fl/fl SCs transdu
(E) TSEA analyses of gene expression from SCs purified from TMX-trea
(F) Relative mRNA expression of the indicated genes in Chd4fl/f or Chd4
normalized to housekeeping gene Rpl7, with the Chd4fl/f set to 1.
(G and H) Functional annotation clustering based on DAVID biologica
FACS-purified SCs, as in (C).TMX-treated Chd4fl/fl and Chd4DPax7ER mice 3 days post
injury. RNA-seq analysis identified 1,721 significantly upre-
gulated genes and 1,226 significantly downregulated genes
in Chd4DPax7ER SCs (Figures 2C), 41% and 47% of which
were similarly up- or downregulated in vitro (Figure S2G).
In agreement with our previous report, Chd4 loss upregu-
lated Ripk3 (Sreenivasan et al., 2020). Furthermore, compar-
ison of the in vitro and in vivo RNA-seq data confirmed
increased expression of p21, a trend toward p57 upregula-
tion, as well as increased expression of the MRFs MyoD
andMyog, involved in SC proliferation and early differenti-
ation, and of genes specific to mature skeletal muscle (Fig-
ures 2D and 2E). Notably, tissue specific expression analysis
(TSEA) further revealed upregulation of genes not related to
the skeletal muscle lineage, including brain-related genes
such as Map1a, Nrdg2, and Usp11, and heart-related genes
such as cardiac troponin T (Tnnt2), which were confirmed
by qRT-PCR (Figures 2F and S2H). These observations,
together with clustering of altered Gene Ontology (GO)
biological process categories via using the database for
annotation, visualization and integrated discovery (DAVID)
(Figure 2G), strongly indicate that SCs requireChd4 to retain
muscle stem cell identity in regeneratingmuscles, especially
during the proliferative phase after injury.
RNA-seq of Chd4-deficient SCs in vivo also identified the
downregulation of two important gene clusters: one
involved in positive regulation of the cell cycle (e.g., cy-
clin-dependent kinase 4 [Cdk4]), and one in DNA damage
repair (e.g., replication protein A1 [Rpa1]); these may
contribute to the observed proliferative phenotype (Fig-
ure 2H). Chd4DPax7ER SCs also showed changes in the
expression of other NuRD complex subunits (e.g., histone
deacetylase 1 [Hdac1]), other CHD family genes (e.g., chro-
modomain helicase DNA-binding protein 5 [Chd5]), his-
tone variants (e.g., histone cluster 1 H1 family member C
[Hist1h1c]), and some Polycomb repressive complex 2
(PRC2) components (e.g., enhancer of zeste 2 [Ezh2]) (Fig-
ure S3A). These changes are particularly important,
pointing to the consequent complexity of dysregulated
epigenetic repression occurring in the absence of Chd4,d lineage-specific genes in SCs
-seq results from Chd4fl/fl SCs transduced with Ad-CRE or Ad-GFP
base of the significantly upregulated and downregulated genes.
days after TMX-induced muscle injury, in Chd4 fl/fl and Chd4DPax7ER
ced with Ad-CRE or Ad-GFP.
ted Chd4 fl/fl or Chd4DPax7ER mice at 3 days after muscle injury.
DPax7ERmice SCs at 3 days after injury (n = 4 mice/group). Data were
l processes of upregulated genes (G) or downregulated genes (H) in
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expression of genes from diverse lineages.
Supporting the transcriptomic data, ATAC-seq analysis of
Chd4-deficient cells sorted 3 days after muscle injury
showed extensive changes in proximal promoters near
transcriptional start sites (TSSs), with 1,600 peaks signifi-
cantly more open (e.g., with more accessible chromatin)
and 1,436 significantly more closed. GO analysis of these
changed genes revealed similar categories to those found
by RNA-seq. For instance, myogenesis and neuronal differ-
entiation gene promoters were significantly more open,
whereas cell-cycle regulation, G2/M checkpoint, and E2F-
regulated proliferation-related gene promoters were signif-
icantly more closed (Figure 3A).
Integration of proteomic and transcriptomic analyses of
Chd4-deficient SCs (Sreenivasan et al., 2020), identified
18 commonly upregulated or downregulated proteins,
including CHD3 and the neural proteins NDRG2, USP11,
and MAP1a (Figure 3B). More importantly, Chd4DPax7ER
SCs displayed inappropriate accessibility of lineage genes
including Map1a, Ndrg2, Myog, Tnnt2, and Chd5 (Fig-
ure 3C). CHD4 binding to these loci was confirmed by
ChIP-qPCR (Figure 3D), indicating direct repression.CHD4 functions in SCs are intrinsic to the NuRD
complex
We analyzed the interaction of other core NuRD subunits
(MTA1 and HDAC1) in the absence of Chd4. Interestingly,
the binding of MTA1 to HDAC1 was significantly reduced
but not completely abolished (Figure S3B), indicating that
CHD4 functions to promote the association of the NuRD
complex to cognate binding sites in SCs. In agreement
with this, histone acetylationwas increased at the promoters
of Chd4-regulated genes (Figure S3C), indicating reduced
HDAC activity of the CHD4/NuRD complex in those pro-
moters. ChIP-PCR analysis of HDAC1 on its cardinal target
p21 gene locus (Mal et al., 2001) showed that the absence
of Chd4 impaired HDAC1 recruitment (Figure S3D). Consis-
tently, inhibition of HDAC1 in WT cells with romidepsin
(Furumai et al., 2002) induced upregulation of the Map1a
and Ndrg2 genes, similarly to Chd4 loss (Figure S3E).Figure 3. Chd4 maintains the transcriptional identity of SCs duri
(A) GO analysis of the genes with differential open (left) and closed
Chd4DPax7ERmice at 3 days after muscle injury (n = 4 mice/group). Data
6.2 Database). Reg, regulation; pol, polymerase. All categories repres
(B) Color map (coded for Log2(fold change)) representing targets com
and protein mass spectrometry of Chd4 fl/fl SCs transduced with Ad-CR
using DESeq2 (RNA-seq) or MaxQuant (mass spectrometry).
(C) Genome browser tracks of ATAC-seq data at the Map1a, Ndrg2, Myog
and Chd4DPax7ER mice at 3 days after muscle injury (overlayed tracks
(D) ChIP-qPCR of Chd4 protein binding to the indicated gene loci. Th
noglobulin G (IgG), which was set to 1 (n = 4 independent experimeAs Chd4 deletion upregulated the expression of Chd3,
we asked if an alternate CHD3/NuRD complex exists
and, if so, whether it could act redundantly. Notably,
Chd3 knockdown reduced the expression of Chd4, and
vice versa (Figure S3F), pointing to a cross-regulation of
both genes in SCs. Knockdown of either Chd3 or Chd4 re-
sulted in a similar reduction of SC proliferation (Figures
1E–1G and S3F). Interestingly, the reduction of SC prolif-
eration by single knockdown of Chd4 or Chd3 was not
increased upon knockdown of both Chd4 and Chd3 (Fig-
ure S3F). These results show that CHD4’s actions in SCs
are integral to the NuRD complex and that the CHD4
and CHD3 complexes may be present in SCs with overlap-
ping functionalities.DISCUSSION
This study dissects novel functional roles of the epigenetic
modifier CHD4 in SCs during skeletal muscle regenera-
tion, including cell identity and cellular expansion. Our
results revealed that Chd4 loss breaks satellite lineage
confinement and allows the expression of genes associ-
ated with other fates, indicating that its function is
required for strict control of muscle lineage plasticity dur-
ing regeneration.
In support of this notion, Chd4 loss induced upregulation
of genes corresponding to multiple lineages in proliferating
SCs, both in vitro andduringmuscle regeneration, including
the brain and neural proteins NDGR2, USP11, and MAP1A
at both the transcript and the protein level. Notably, Chd4
depletion also triggered the upregulation of Chd5, which
encodes a neural-specific chromatin remodeler in the
same CHD family as CHD3 and CHD4. CHD5 activates
neuronal genes required for terminal neuronal differentia-
tion (Egan et al., 2013; Potts et al., 2011). Therefore, it is
tempting to speculate that CHD5 could be responsible for
de-repression of neural genes, in an NuRD-dependent or
-independent manner. Also, Chd4 loss significantly upregu-
lated the expression of cardiac-specific genes, in agreement
with our previous studies showing inappropriate expression
of cardiac sarcomeric genes in Chd4-deficient matureng muscle regeneration
(right) chromatin from SCs obtained from TMX-treated Chd4 fl/fl or
were analyzed using gene set enrichment analysis (GSEA) (MySigDB
ented obtained p < 0.0001.
monly found to be differentially expressed (p < 0.01) in the RNA-seq
E or Ad-GFP (n = 4 independent experiments). Data were analyzed
, Tnnt2, and Chd5 loci from SCs obtained from TMX-treated Chd4 fl/fl
of n = 4 mice).
e Tbx21 gene was used as control. Data were normalized to immu-
nts).
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chromatin accessibility and chromatin binding assays
confirmed that Map1a, Ndrg2, Myog, Tnnt2, and Chd5 are
direct CHD4 targets, which explains the loss of their expres-
sion in the absence of Chd4. Chd4 depletion also changed
the gene expression profiles of the Chd4 homolog Chd3
and epigenetic modulators Ezh2 and Suz12. The cross-regu-
lation of Chd4 and Chd3 in SCs indicates that several NuRD
complexes control SC proliferation, even though the CHD3
and CHD4 proteins form distinct NuRD complexes with
specific target genes (Hoffmeister et al., 2017). This func-
tional substitution of CHD4 by either CHD3 or CHD5
may contribute to the observed stem cell lineage-loss
phenotype. The biological implication of these changes
upon Chd4 depletion in SCs remains to be determined,
despite reports of Ezh2 controlling SC identity (Juan et al.,
2011). The results presented here show that CHD4 exerts
a tight control on muscle stem cell fate commitment and
lineage fidelity, acting as a master transcriptional repressor
of non-muscle lineage genes and of differentiation-specific
myogenic genes during the proliferative expansion of SCs.
These CHD4-regulated processes are essential for the regen-
erative functions of muscle stem cells.EXPERIMENTAL PROCEDURES
Mice
The satellite cell-specific Chd4 transgenic mouse model
(Chd4DPax7ER) was generated by crossingmice that express CreERT2
from the Pax7 promoter (Pax7CRE-ER) with Chd4-floxed mice
(Chd4fl/fl)) to generate Chd4DPax7ER mice. p57 conditional mice
were used to generate Chd4DPax7ER/p57DPax7ER mice. Genetic abla-
tion was induced by injection of 100 mL of tamoxifen (TMX)
(T5648, Sigma-Aldrich, 20 mg/mL in corn oil) intraperitoneally
for four consecutive days. Chd4fl/fl mice were used as control
for the TMX treatment. Regeneration of skeletal muscle was
induced by intramuscular injection of cardiotoxin (CTX; Latoxan,
105 M). The Catalan Government approved the work protocols,
following applicable legislation. Both male and female mice were
used in each experiment unless stated otherwise. Live colonies
were maintained and genotyped as per Jackson Laboratories’
guidelines and protocols. Mice were housed together, health was
monitored daily for sickness symptoms, and euthanized immedi-
ately at the clinical endpoint when recommended by veterinary
and biological services staff members.SC isolation culture, immunohistochemistry, and
cellular assays
A detailed description is provided in supplemental experimental
procedures.RNA-seq and ATAC-seq, ChIP, and RT-qPCR
A detailed description is provided in supplemental experimental
procedures.8 Stem Cell Reports j Vol. 16 j 1–10 j September 14, 2021Statistical analysis
Data were analyzed using GraphPad Prism 8.0. The sample size (n)
of each experimental group is described in each corresponding
figure legend, and all experiments were repeated at least with three
biological replicates. Data presented as mean ± SD. p < 0.05 was
considered statistically significant. Mann-Whitney U test (inde-
pendent samples, two sided) was used for pairwise comparisons
among groups at each time point.
Data and code availability
RNA-seq and ATAC-seq data have been deposited in the Gene
Expression Omnibus (GEO) under accession code GSE179683.
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Supplemental information can be found online at https://doi.org/
10.1016/j.stemcr.2021.07.022.
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Figure S1, Related to Figure 1. (A) Chd4 mRNA expression in FACS-isolated satellite cells 
from Chd4 fl/fl or Chd4ΔPax7ER mice at 30 days after tamoxifen treatment. Data were normalized to 
the housekeeping gene Rpl7 (n = 6 or 4 mice, respectively). (B) Representative pictures and 
fiber size distribution of uninjured muscles from tamoxifen-treated Chd4 fl/fl or Chd4ΔPax7ER mice 
(n = 4 mice/group). Scale bar, 50 µm. (C) Satellite cell numbers in muscles of Chd4 fl/fl and 
Chd4ΔPax7ER mice at 14 days (left, n = 4 mice/group) and 90 days (right, n = 4 or 5 mice, 
respectively) after tamoxifen treatment. (D) Representative pictures and fiber size distribution of 
muscles from tamoxifen-treated Chd4 fl/fl or Chd4ΔPax7ER mice at 14 days post-injury (n = 3 mice/
group). Scale bar, 50 µm. (E) Representative pictures and fiber size distribution of muscles from 
tamoxifen-treated Chd4 fl/fland Chd4ΔPax7ER mice at 21 days post-injury (n = 3 mice/group). Scale 
bar, 50 µm. (F) Representative pictures and fiber size distribution of muscles from tamoxifen-
treated Chd4 fl/fl or Chd4ΔPax7ER mice at 14 days post-injury (n = 5 or 4 mice, respectively). Scale 
bar, 50 µm. (G) Chd4 mRNA relative expression and proliferation rate in satellite cells from 
Chd4 fl/fl satellite cells transduced with Ad-CRE or Ad-GFP (control) and examined after 48 h (n 
= 4 or 5 independent experiments, respectively) or 72 h (n = 6 or 5 independent experiments, 
respectively). Representative pictures of BrdU-stained cells are shown. Scale bar, 50 µm. (H) 
Proportion of quiescent (Pax7+/Ki67–) satellite cells in muscles from tamoxifen-treated Chd4 fl/fl 
or Chd4ΔPax7ER mice at 21 days post-injury (n = 4 mice/group). 
(I) Representative pictures of nuclei and dystrophin staining of muscles from tamoxifen-treated 
Chd4 fl/fl or Chd4ΔPax7ER mice at 7 days post-injury. Quantification of nuclei number inside the 
myofibers is shown (n = 4 or 5 mice, respectively). Scale bar, 50 µm. (J) Representative pictures 
of cultured myotubes derived from satellite cells of Chd4 fl/fl mice transduced with Ad-CRE or 
Ad-GFP (control) and cultured in DM for 48 h. The proportion of myotubes containing the 
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Figure S2, Related to Figure 2. (A, B) mRNA expression in FACS-purified satellite cells at 3 
days after muscle injury from tamoxifen-treatment of Chd4 fl/fl or Chd4ΔPax7ER mice. Data were 
normalized to the housekeeping gene Rpl7, with the Chd4 fl/fl set to 1 (n = 11 mice/group for 
Myog, and n= 10 mice/group for Cdkn1c). (C) ChIP-PCR analysis of the Cdkn1c (p57) 
promoter region showing binding of the Chd4 protein. Qualitative PCR gel pictures (left) and 
qPCR analysis (right) are shown. n = 3 samples/group from two biological replicates. (D) 
shRNA-mediated knockdown of p57 (left) with a lentiviral vector (shRNA p57) in Chd4ΔPax7ER 
satellite cells (n= 3 independent experiments); percentage of proliferating satellite cells at 72 h 
after p57 silencing as compared to control sRNA-scramble cells, is shown (right) (n = 6, 3, and 
3 independent experiments, respectively). (E) Quantification of proliferating cells and 
frequency distribution of cross-sectional area (μm2) of regenerating fibres from tamoxifen-
treated Chd4 fl/fl, Chd4ΔPax7ER and Chd4ΔPax7ER/p57ΔPax7ER double-mutant mice at 3 or 7 days post-
injury (n= 3 mice/group). (F) Relative mRNA expression of the indicated genes in SCs from 
Chd4fl/f or Chd4ΔPax7ER/p57ΔPax7ER mice at 3 days post-injury (n = 4 mice/group). Data were 
normalized to the housekeeping gene Rpl7 with the Chd4fl/f set to 1.  (G) Venn diagram showing 
the common significantly (p < 0.01) upregulated or downregulated genes in the RNA-seq of Ad-
CRE or Ad-GFP-treated Chd4 fl/fl SCs (n = 4 independent experiments), and the RNA-seq of SCs 
obtained from tamoxifen-treated Chd4 fl/fl or Chd4ΔPax7ER mice isolated at 3 days post-injury of 
muscle (n= 4 mice/group). Data analyzed using DESeq2. (H) Relative mRNA expression of the 
indicated genes in Chd4fl/fl SCs transduced with Ad-CRE or Ad-GFP for 48 h. Data were 
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Figure S3, Related to Figure 3. (A) Reads per kilobase per million mapped reads (RPKM) of 
the indicated NuRD complex components, members of the chromodomain helicase DNA-
binding (CHD) family, histone variants, and components of the PRC2 complex obtained in the 
RNA-seq of SCs from tamoxifen-treated Chd4 fl/fl or Chd4ΔPax7ER mice, isolated three days post-
injury to muscle (n = 4 mice/group). Data were analyzed using DESeq2. (B) Western blots of 
co-immunoprecipitation (IP) experiments showing interactions between MTA1 and HDAC1 in 
Chd4fl/fl SCs transduced with Ad-CRE or Ad-GFP for 48 h. Left, input blots, showing also 
CHD4 and GAPDH as a control; right, blots of MTA1 and HDAC1 from IP, performed using 
HDAC1 and IgG antibodies. Quantification of three different experiments is shown. (C) ChIP-
qPCR of H4 pan-acetyl protein from Chd4fl/fl SCs transduced with Ad-CRE or Ad-GFP for 48 h 
at the indicated genes loci. Data were normalized to IgG (set to 1) (n = 4 independent 
experiments). (D) ChIP-qPCR of HDAC1 protein from Chd4fl/fl SCs transduced with Ad-CRE 
or Ad-GFP for 48 h at the p21 loci. Data were normalized to IgG (set to 1) (n = 4 independent 
experiments). (E) Effects of HDAC1 inhibition with romidepsin (5 or 10 nM concentrations) in 
WT SCs on the expression of the indicated genes. Data were normalized to the housekeeping 
gene Rpl7, with the control cells set to 1 (n = 4 independent experiments). (F) siRNA-mediated 
knockdown of Chd4, Chd3, or both genes using siRNA pools in WT SCs (n = 6 independent 
experiments). Left, efficiency of the knockdown on Chd4 and Chd3 gene expression; right, 






Supplemental Experimental Procedures 
 
Mice 
For mouse experiments, no specific blinding method was used but mice in each sample group 
were selected randomly.  
 
Isolation of satellite cells by fluorescence-activated cell sorting (FACS) 
Dissection of fore and hind limb muscles was done with a scalpel and retrieved in cold DMEM 
(Dulbecco's Modified Eagle Medium, Gibco). Muscle tissues were finely minced and digested 
with Liberase 5 mg/mL (Roche/Sigma Aldrich), 0.03% Dispase II (Sigma), DMEM, 1% 
penicillin/streptomycin, BSA 0.2% (Sigma), 1 M CaCl2, and 1 M MgCl2 at 37ºC. Samples were 
then centrifuged 10 min at 50g at 4ºC. Supernatant was filtered through 100-µm and then a 70-
µm cell strainers filters and then centrifuged at 1700 rpm for 15 min. Pellets were then 
resuspended in Lysis Buffer 1 (BD) and incubated for 10 min. Samples were resuspended in 
cold DMEM, filtered through 40-µm cell strainer filters, and centrifuged again for 15 min at 
1700 rpm. Cells were resuspended in PBS, and 2.5% of goat serum (FACS buffer). Samples 
were incubated 30 min at 4ºC with the following antibodies: anti-CD45 PE-Cy7 (Biolegend), 
anti-Sca1 PE-Cy7 (Biolegend), anti-α7-integrin PE (Ablab.ca), and anti-CD34 Alexa-647 
(BDPharmingen). Samples were centrifuged at 1700 rpm for 15 min and finally resuspended in 
FACS buffer with 1 μg/mL DAPI. After antibody labelling, SCA1–/CD45–/α7-integrin+/CD34+ 
cells were sorted by fluorescence-activated cell sorting (FACS) in the BD Influx cell sorter, and 
then cultured as described. 
 
Satellite cell culture 
Freshly isolated satellite cells from Pax7CreERT2/+/Chd4fl/fl or Chd4fl/fl mice were cultured on 
collagen-coated dishes with HAM’s F10 medium (Gibco), 20% Fetal Bovine Serum (FBS), 
1:10000 Fibroblast Growth Factor (FGF) and 1% penicillin/streptomycin and kept in an 
incubator (37ºC, 5% CO2). In vitro genetic ablation of Chd4 was induced by Adenovirus-Cre 
1:2000 transduction during 48 h. Adenovirus-GFP 1:2000 transduction was used as control. 
 
Cell and tissue immunohistochemistry 
Tissue samples from tibialis anterior muscles were embedded in optimal cutting temperature 
(OCT) and frozen in liquid nitrogen-cooled isopentane. Sections (10-μm-thick) were collected 
and either stained with hematoxylin and eosin (H&E) or immunostained. Freshly isolated or 
cultured satellite cells were fixed with 4% formaldehyde. Samples were rinsed with PBS, 
permeabilized with 0.5% Triton X-100 in PBS for 10 min at room temperature, rinsed again 
with PBS, and then incubated in blocking solution (10% goat serum, 5% BSA) before applying 
the indicated primary antibodies. For Pax7, Ki67, dystrophin and myogenin immunostainings, 
samples were incubated for 20 min in 4% PFA, washed with PBS and incubated for 6 min in 
cold methanol. Sections were then washed with PBS, followed by an antigen retrieval procedure 
(incubation twice for 5 min at 100 ºC with citric acid 0.1 M pH 6). Afterwards, slides were 
washed with PBS again and incubated for 2 h in blocking solution (5% BSA IgG-Free with 10% 
goat serum), followed by a wash with PBS and incubation during 30 min with M.O.M blocking 
solution (Vector Laboratories). Samples incubated overnight at 4ºC with a primary antibody 
against Pax7 (sc-81648 Santa Cruz, diluted 1/50 in blocking solution), Ki67 (ab15580, Abcam, 
diluted 1/100 in blocking solution), dystrophin (Sigma D8168, 1/400), or  MyoG (sc-576, Santa 
Cruz, diluted 1/50). After PBS washing, samples were incubated with the appropriated 
secondary antibody (Rhodamine Red-X (RRX) AffiniPure Goat Anti-Mouse IgG1, no. 115-
295-205; Alexa Fluor 488 AffiniPure Goat AntiRabbit IgG, no. 111-545-144; both from 
Jackson ImmunoResearch; both were diluted 1/400 in PBS and 1% BSA for use) and rinsed 
with PBS; nuclei were stained with DAPI (1 μg/mL in PBS) before mounting with Fluoromount 
(Sigma). For embryonic myosin heavy chain (eMHC) immunostaining, samples were incubated 
for 30 min with 0.3% H2O2, washed with PBS, and incubated 1 h with M.O.M blocking solution 




Developmental Studies Hybridoma Bank, undiluted), followed by three PBS washes and 
incubation with secondary antibody (M.O.M. biotinylated anti-mouse IgG, Vector Laboratories, 
1/250 in PBS). Samples were washed with PBS and then incubated with M.O.M ABC solution 
for 5 min. Slides were then briefly incubated with 3,3'-diaminobenzidine (DAB), and the 
reaction was stopped by adding H2O. Slides were dehydrated with ethanol, cleared in xylol, and 
mounted in di(n-butyl)phthalate in xylene solution (DPX, Sigma-Aldrich). Images were taken 
using the Zeiss Cell Observer HS widefield microscope with a Zen Blue software, and the 
image analysis was performed using Fiji image analysis software. 
BrdU and EdU incorporation assays  
Cultured satellite cells were incubated with BrdU (1.5 μg/mL; Sigma) for 1 h and fixed with 
formaldehyde 3.7%. Samples were then washed twice with PBS and incubated during 45 min 
with 1 M HCl at 45ºC, and washed and further incubated for 10 min with 0.1 M borate buffer 
(7.8 g sodium tetraborate, 4.96 g boric acid, 4L H2O) at room temperature. Blocking solution 
(5% donkey serum, 0.5% BSA, 0.25% Triton X-100) was added for 1 h at room temperature. 
The primary antibody rat anti-BrdU (Ab6326 Abcam, diluted 1/500 in blocking solution) was 
added and incubated overnight at 4ºC. Samples were then rinsed 3 times with PBS-Tween 
0.025% and then incubated with the secondary antibody biotin-Donkey anti-rat (712-066-150 
Jackson ImmunoResearch, diluted 1/250 in PBS-Tween 0.025%) for 1 h at room temperature. 
Samples were washed 3 times with PBS-Tween and then incubated for 30 min with the 
VECTASTAIN Elite ABC-HRP solution (Vector Labs) at room temperature. Cells were then 
washed 3 times in PBS-Tween and finally incubated briefly with DAB solution (10 ml PBS, 60 
µl DAB 50 µg/ml, 2 µl H2O2 30%). The reaction was stopped using distilled water. Samples 
were stored in PBS and 0.025% sodium azide. EdU incorporation assay was performed with 
Click-iT™ EdU Cell Proliferation Kit for Imaging (Invitrogen) following manufacturer’s 
instructions. Images were taken using the Zeiss Cell Observer HS widefield microscope with 
Zen Blue software and the image analysis was performed using Fiji image processing software. 
Clonogenic assay  
FACS-purified satellite cells were cultured as described in collagen-coated 96 well plates. Total 
number of cells and colonies were manually counted progressively throughout 4 days.  
 
Time-Lapse Live microscopy  
FACS-purified satellite cells were plated in collagen coated µ-Slide Angiogenesis (Ibidi) plates 
with 1:1 DMEM:HAMs F10 medium containing 20% serum FBS and ITS (Insulin, Transferrin 
and Selenium; GIBCO) and recorded during 72 h using the Zeiss Cell Observer HS widefield 
microscope with Zen Blue software. The number of cell divisions and the time for every 
division was analyzed manually using Fiji image processing software. 
 
RNA isolation 
For qPCR and in vitro-based RNA-Seq, total RNA was isolated from cultured satellite cells 
with the RNeasy Micro kit (QIAGEN) with on-column DNA digestion. For the RNA-Seq 
experiment in freshly isolated cells, total RNA was extracted with the Arcturus PicoPure RNA 
Isolation Kit (Thermo Fisher) together with on-column DNA digestion. Both RNA isolation kits 
were used according to the manufacturer's instructions. RNA concentration was measured with 
NanoDrop 2000/2000c (Thermo Fisher). 
 
cDNA and qPCR 
Reverse transcription of RNA into cDNA was performed by random-primed reverse 
transcription using the SuperScript II reverse transcriptase (Invitrogen). cDNA quantification 
was obtained by real-time qPCR (LightCycler 480, Roche) using PowerUp SYBR Green 
Universal (Thermo Fisher) according to the manufacturer's instructions. Primers used for qPCR 
are depicted in Supplemental table 1. Rpl7 transcript levels were used as a reference for the 





Protein Mass Spectrometry 
Whole-cell lysates were run on SDS-PAGE gels and stained with colloidal protein staining 
solution (Invitrogen). The gels were subjected to digestion with trypsin. Released peptides were 
measured using LTQ-Orbitrap Velos mass spectrometer (Thermo Fisher Scientific) equipped 
with a nanoelectrospray source (Proxeon). Raw data from (Sreenivasan et al., 2020) was 
analyzed using the MaxQuant software package 1.6.1.0. 
 
RNA sequencing 
RNA isolation, cDNA, and qPCR are indicated in Supplemental information. RNA integrity and 
library preparation were checked with a BioAnalyzer (RNA Pico Chip, Agilent). For the in 
vitro-based RNA-Seq, low input library preparation and single-end sequencing was performed 
in the Centre de Regulació Genomica (CRG) genomics unit using the HiSeqTM Sequencing Kit 
and the TruSeq v3 Cluster (Illumina). For the RNA-seq experiment in freshly isolated cells 
standard Directional RNA-seq library preparation and single-end sequencing (Illumina HiSeq 
2500) was performed in the Genomic Unit of Centro Nacional de Investigaciones 
Cardiovasculares (CNIC). For both datasets RNA-Seq raw reads were assessed for quality, 
adaptor content and duplication rates with FastQC 0.11.8, trimmed by Cutadapt 1.18 and 
terminally aligned to the Ensemble mouse genome version mm10 (GRCm38) by HISAT2 2.1.0. 
Differentially expressed genes were identified using DESeq2 3.6. Only genes with a minimal p-
value of 0.01 were classified as significantly differentially expressed. Gene ontology (GO) 
analysis was performed using Gene Set Enrichment Analysis (GSEA) using MSigDB 6.2 
database. Functional annotation clustering was done using DAVID 6.8. 
 
ATAC Sequencing 
Library preparation was done on FACS-purified satellite cells following the Omni-ATAC 
protocol ( http://www.nature.com/articles/nmeth.4396). Time of incubation with transposase 
was set to 40 min after extensive setup with Chd4 fl/fl satellite cells. Primers used for 
amplification and sequencing are stated in Supplemental table 2. Library quality was assessed 
by Agilent BioAnalyzer (DNA High Sensitivity Chip). Paired-end sequencing (Illumina HiSeq 
2500) was performed in the Genomic Unit of the CRG. Raw reads were assessed for quality, 
adaptor content and duplication rates with FastQC 0.11.8, trimmed by Cutadapt 1.18 and 
terminally aligned to the Ensemble mouse genome version mm10 (GRCm38) by Picard 2.18.15. 
Regions of open chromatin were identified by MACS2 2.1.2 while HOMER was used for peak 
annotation. Differentially peaks near the Transcriptional Start Site (TSS ± 500 bp) were 
identified using DESeq2 3.6 (p < 0.01). Gene ontology analysis was performed using Gene Set 
Enrichment Analysis (GSEA) using MSigDB 6.2 database. 
 
ChIP and RT–qPCR 
Chromatin immunoprecipitation (ChIP) experiments were performed as previously described 
(Gomez-del Arco et al., 2016)(Sreenivasan et al., 2020) Chromatin Shearing Kit with SDS 
(Covaris) was used for chromatin shearing. Briefly, cells were fixed using 1% formaldehyde for 
10 minutes and the reaction was quenched with 0.125M glycine for 5 minutes at room 
temperature. The chromatin were sheared to approximately 300-500bp using Bioruptor 
(Diagenode). Sheared chromatin was subjected to immunoprecipitation with indicated 
antibodies. Corresponding mouse or rabbit IgG antibody served as a negative control. 
Chromatin DNA was verified via quantitative real-time PCR. Primers used in this study are 
listed in Supplemental Table 1.  
Co-immunoprecipitation and western blot analysis 
SCs were harvested from Chd4fl/fl mice. Genetic ablation of Chd4 was induced in vitro by adenoviral 
transduction with a recombinant adenovirus harboring the Cre recombinase (AdCRE).  Control cells 
were infected with green fluorescent protein (GFP)-expressing virus (AdGFP). Co-
immunoprecipitation and western blot analysis was performed as previously described (Ianni et al., 
2021), 72 h post-transduction. In this study, anti-HDAC1 antibody (Cell Signaling Technology; 5356) 




(Cell Signaling Technology; 5647) and anti-CHD4 (Cell Signaling Technology; 12011) antibodies for 
western blot analysis.  
 
Quantification of Western blot bands and statistical analysis 
Intensity of bands was quantified using Image Lab™ software (version 6.0.1; Bio-Rad laboratories) 
and normalized to loading control (GAPDH). The normalized signal of the control sample for each 
experiment was set to 100. The abundance of target protein is displayed as fold-change relative to 
controls (relative expression). Statistical significance was assessed by paired Student’s t-test using 




RNA–seq and ATAC-seq data have been deposited in the Gene Expression Omnibus (GEO) 
under accession code GSE179683. All other data supporting the findings of this study are 







Table S1. ChIP and qPCR primers and sequences 
 
Gene  Forward primer (5 – 3) Reverse primer (5 – 3) 
Rpl7 GAAGCTCATCTATGAGAAGGC AAGACGAAGGAGCTGCAGAAC 
Chd4 AAGGCCATTGAACGACTGCT CTCCTCTTCCTCCCCCATCT 
p57 CGAGGAGCAGGACGAGAATC GAAGAAGTCGTTCGCATTGGC 
Ndrg2 CAAGGCATGGGCTACATGGC GGAGAGTCCCAGACTCGCTA 
 
Map1a GGGGAGAACCTTCAGGTGAC GACCAGGACGTTCAGTTGCT 
 
Usp11 ATGCGTGATGGACACTATAC GGCGCTGATAGAACAAGACA 




ChIP qPCR primers 
MyoG TTATCTGGCTGGGAAGTGGC GGCAAGGAAGGACAGAGACC 
Tnnt2 GACAGTTGGTGGTGGGAGAG AGCAGGGAGGTAGACCAGAG 
Tbx21 CATACAGGAGGCAGCAACAA TTTCTCTCCCCCAGGAAGTT 
Chd5 GGCCCATTGGAGGGGTTATT ATTTCTCGGGTACCCTCCGT 
Chd3 GGGGGTAGAGAGAAGTCGAAAA GCACCACCCCCAAAAATGTTC 
Sil1 TAATAGCCACGCGCCTTCA CCACCTCCCCTACCTTCGG 




Usp11 TCCTTTGTGAGGCCCTAAACAC TCTGCAACCAATACCAGGGG 












Table S2. Primers used for the ATAC-seq, Related to Figure 3 





















Ad1_noMX is the common primer for all samples, while the other primers are specific for each 
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